PharmD Live
MAY 30, 2024
People over 65 make up only 14% of the population but account for 56% of hospitalizations for adverse drug events (ADEs) (Agency for Healthcare Research and Quality, AHRQ, 2021). Emergency Hospitalizations for Adverse Drug Events in Older Americans. Clinical Consequences of Polypharmacy in Elderly. References: Budnitz, D.
pharmaphorum
APRIL 6, 2021
Taking place as a fully interactive digital event, this is y our chance to hear the latest advances and innovations in the preclinical cell therapy space. Download the full event guide here for more information on what you can look forward to.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
MARCH 21, 2023
In September 2022, Zydus had announced positive Phase 2 proof-of-concept (POC) study in CAPS patients, and the publication of Phase 1 study results in Clinical Pharmacology in Drug Development, supporting the advancement of ZYIL1 into pivotal clinical trials in CAPS patients.
pharmaphorum
NOVEMBER 1, 2022
In 2023 we will see the return of SAE’s RNA Therapeutics conference to a live in-person event, showcasing an update on mRNA therapeutic applications, coupled with an industry outlook of the field. Director, Clinical Pharmacology. Clinical Science Director. Chief Medical Officers. Chief Technical Officers. Head of Biology.
European Pharmaceutical Review
JULY 13, 2023
5 When these medicines are prescribed to patients, we can use feedback from the real-world data that documents clinical outcomes, efficacy measures, patient-reported outcomes, and adverse events. An observational study of safety and clinical outcome measures across patient groups in the United Kingdom Medical Cannabis Registry.
The Thyroid Pharmacist
DECEMBER 28, 2022
Interestingly, Dr. Robert Krysiak and colleagues from the Department of Internal Medicine and Clinical Pharmacology at the Medical University of Silesia in Katowice, Poland, published an article about the benefits of the gluten-free diet in Hashimoto’s in 2019. References. Harvard Health Publishing. Understanding the stress response.
European Pharmaceutical Review
SEPTEMBER 29, 2022
Ninety-eight participants reported treatment emergent adverse events (TEAEs), with the majority considered drug-related and attributed to ISRs. There were no life threatening TEAEs, TEAEs leading to premature discontinuation of study, serious adverse events (SAEs) or deaths.
Expert insights. Personalized for you.
119 
Let's personalize your content